NTRA 127.13 (+0.02%)
US6323071042Medical Diagnostics & ResearchDiagnostics & Research

Natera (NTRA) Competitor Comparison

We are evaluating the key criteria listed to compare Natera (NTRA) against its competitors in the Diagnostics & Research industry.

Performance 10 years - NTRA ranking 6 / 58

These are the competitors of Natera in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.62K
3. Medpace Holdings MEDP
1.15K
4. RadNet RDNT
782.68
5. IDEXX Laboratories IDXX
714.56
6. Natera NTRA
602.83
7. DexCom DXCM
552.68
8. Icon ICLR
440.25
9. Danaher DHR
429.75
10. Mettler-Toledo MTD
413.06
11. Thermo Fisher Scientific TMO
396.68
12. IQVIA Holdings IQV
313.83
13. Twist Bioscience TWST
261.15
14. PerkinElmer PKI
247.07
15. Agilent Technologies A
228.14
16. Charles River Laboratories CRL
227.2
17. Waters WAT
220.04
18. Exact Sciences EXAS
211.65
19. CareDx CDNA
185.56
20. NeoGenomics NEO
175.63
21. Quest Diagnostics DGX
146.22
22. Fulgent Genetics FLGT
142.67
23. Laboratory Corp of America Holdings LH
141.38
24. Syneos Health SYNH
113.83
25. Qiagen QGEN
88.1
26. Meridian Bioscience VIVO
60.69
27. National Research NRC
52.08
28. Ortho Clinical Diagnostics Holdings OCDX
13.74
29. Neogen NEOG
3.62
30. Guardant Health GH
-3.46
31. Illumina ILMN
-23.13
32. Myriad Genetics MYGN
-23.45
33. Bioventus BVS
-26.03
34. Olink Holding OLK
-26.82
35. Inotiv NOTV
-28.44
36. Sotera Health SHC
-37.78
37. Anixa Biosciences ANIX
-41.74
38. Sera Prognostics SERA
-48.97
39. Pacific Biosciences of California PACB
-65.59
40. Global Cord Blood CO
-66.57
41. DarioHealth DRIO
-75.47
42. Personalis PSNL
-75.89
43. MaxCyte MXCT
-76.28
44. Co-Diagnostics CODX
-78.17
45. MDxHealth MDXH
-78.44
46. bioAffinity Technologies BIAF
-79.29
47. Enzo Biochem ENZ
-80.93
48. Exagen XGN
-82.38
49. Psychemedics PMD
-83.18
50. Biodesix BDSX
-86.98
51. Trinity Biotech TRIB
-92.2
52. SeqLL SQL
-95.22
53. Prenetics Global PRE
-96.24
54. Neuronetics STIM
-97
55. Aspira Womens Health AWH
-97.44
56. Organovo Holdings ONVO
-99.26
57. Interpace Biosciences IDXG
-99.45
58. Precipio PRPO
-99.76

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.